|
Simion A.Yu., Ovsyannikov E.S., Drobysheva E.S.
Influence of anemic syndrome in patients with coronary heart disease on the main parameters of quality of life
|
№4 (приложение) / 2022
|
|
Vasilyeva L.V., Suslova E.Yu., Gosteva E.V.
Pathogenic factors of Helicobacter pylori in patients with coronary heart disease in combination with peptic ulcer
|
№4 (приложение) / 2022
|
|
Mikhin V.P., Nikolenko T.A., Gromnatsky N.I.
The role of cytoprotectors in the treatment of patients with chronic forms of coronary heart disease
|
№4 / 2021
|
|
Borovkova N.Yu., Buyanova M.V., Bakka T.E., Nistratova M.P.
Pathogenetic approaches to treatment of aspirin-induced gastroenteropathies in case of long-term intake of acetylsalicylic acid in patients with chronic ischemic heart disease
|
№3 / 2020
|
|
E.O. Taratukhin
Clopidogrel – historical and modern base of antiplatelet therapy in acute coronary syndrome
|
№6 / 2017
|
|
Ye.S. Levitskaya, M.M. Batyushin
Predicting the risk of development of cerebral stroke in patients in the remote period after myocardial revascularization taking into account renal risk factors
|
№5 / 2016
|
|
A.I. Martynov, Ye.V. Akatova, O.P. Nikolin, I.V. Urlayeva
Type A behavior as a risk factor of acute coronary syndrom
|
№1 / 2016
|
|
G.L. Yurenev, A.N. Kazyulin, T.V. Yureneva-Tkhorzhevskaya
The influence of acid-suppressive therapy on the clinical course of ischemic heart disease with refractory pain syndrome in the chest
|
№2 / 2015
|
Русский
